Cargando…
Programmed Cell Death Protein-1 Predicts the Recurrence of Breast Cancer in Patients Subjected to Radiotherapy After Breast-Preserving Surgery
Radiotherapy is the most important component of the comprehensive treatment of breast cancer, and immunocompromised patients respond with lower response rate. However, the role of programmed cell death protein-1, a critical immune molecule, in recurrence of breast cancer subjected to radiotherapy is...
Autores principales: | Huang, Ruyi, Cui, Yiyao, Guo, Yujiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102752/ https://www.ncbi.nlm.nih.gov/pubmed/30122122 http://dx.doi.org/10.1177/1533033818793425 |
Ejemplares similares
-
Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective
por: Elfgen, Constanze, et al.
Publicado: (2020) -
Radiotherapy refusal in breast cancer with breast-conserving surgery
por: Liu, Jiameng, et al.
Publicado: (2023) -
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients
por: Wang, Jiangfeng, et al.
Publicado: (2020) -
Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy
por: Bayoumi, Yasser, et al.
Publicado: (2014) -
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis
por: Punglia, Rinaa S, et al.
Publicado: (2010)